uniQure N.V. - Ordinary Shares (QURE)
QURE moved a median of +0.23% 30 minutes after news, and +0.76% by the close. How QURE actually reacts to news — the realized, point-in-time move the market made, measured across 921 labeled events over the last three years with zero look-ahead.
QURE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.04% | 51% | 913 |
| 30-min | +0.23% | 54% | 916 |
| 60-min | +0.35% | 56% | 916 |
| to close | +0.76% | 59% | 908 |
| Middle 50% of QURE reactions | -1.33% to +2.27% |
|---|---|
| Median reaction (30-min) | +0.23% |
| Measured reactions | 921 |
Half of all uniQure N.V. - Ordinary Shares news events land between -1.33% and +2.27% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How QURE reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 37 | -1.45% | 38% | +1.35% |
| Analyst downgrades | 21 | -2.23% | 14% | -1.31% |
| Coverage initiations | 11 | +2.65% | 73% | -2.19% |
| Rating reiterations | 123 | 0.00% | 50% | +0.56% |
| Price-target raises | 21 | +0.31% | 57% | +4.08% |
| Price-target cuts | 14 | -0.25% | 43% | -0.52% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how QURE ranks against every other measured name →
That’s how QURE usually reacts — get an email when it moves on news →Email me when QURE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to QURE's baseline. Nothing else.
Recent QURE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.36% | -1.54% | |
| uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.24% | +2.59% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages uniQure N.V. (QURE) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.16% | +0.44% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against uniQure N.V. (QURE) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +1.09% | +2.46% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.13% | +1.09% | |
| uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.25% | +3.99% | |
| Form 8-K uniQure N.V. For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | +3.19% | +2.77% | |
| QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law | Press release | Business Wire | +1.03% | +3.00% | |
| Form 8-K uniQure N.V. For: Sep 02 | SEC filing · Form 8-K | SEC EDGAR | -2.26% | -8.85% | |
| uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease | Press release | GlobeNewswire | -2.26% | -8.85% | |
| Form 10-Q uniQure N.V. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +4.87% | +5.45% | |
| Form 8-K uniQure N.V. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +4.87% | +5.45% | |
| Form S-8 uniQure N.V. | SEC filing · Form S-8 | SEC EDGAR | +4.87% | +5.45% | |
| uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares | Press release | GlobeNewswire | -0.06% | -3.04% | |
| Form 8-K uniQure N.V. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | +1.68% | +0.00% | |
| uniQure Announces Pricing of Upsized $225 Million Public Offering | Press release | GlobeNewswire | -5.43% | -2.30% | |
| Form 8-K uniQure N.V. For: Jun 19 | SEC filing · Form 8-K | SEC EDGAR | +3.69% | -4.13% | |
| uniQure Announces $150 Million Proposed Public Offering | Press release | GlobeNewswire | +6.52% | +10.28% | |
| uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy | Press release | GlobeNewswire | +3.69% | -4.13% | |
| Form 8-K uniQure N.V. For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +2.13% | +10.89% | |
| Form 8-K uniQure N.V. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | -0.58% | -2.74% | |
| Form 10-Q uniQure N.V. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.02% | +5.22% | |
| Form 8-K uniQure N.V. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | +5.22% | |
| Form 8-K uniQure N.V. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | -0.06% | +11.89% | |
| uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease | Press release | GlobeNewswire | -0.06% | +11.89% | |
| Form ARS uniQure N.V. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.60% | -1.86% | |
| Form DEF 14A uniQure N.V. For: Jun 10 | SEC filing · Form DEF | SEC EDGAR | +0.60% | -1.86% | |
| Form DEFA14A uniQure N.V. | SEC filing · Form DEFA14A | SEC EDGAR | +0.60% | -1.86% | |
| Form PRE 14A uniQure N.V. For: Jun 10 | SEC filing · Form PRE | SEC EDGAR | +1.58% | +3.11% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | -0.05% | +15.76% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | -0.35% | +0.81% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | -0.41% | +0.41% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | +1.49% | +17.81% | |
| REMINDER: uniQure N.V. Investors With Significant Losses Must Act By April 13, 2026 | Press release | ACCESS Newswire | +1.76% | -0.44% | |
| Form 10-K uniQure N.V. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.93% | +14.26% | |
| Form 8-K uniQure N.V. For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | +0.93% | +14.26% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | +0.93% | +14.26% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | -2.46% | -8.49% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | +2.73% | +5.86% | |
| uniQure to Announce 2025 Financial Results | Press release | GlobeNewswire | +2.73% | +5.86% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | +0.04% | -1.80% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE | Press release | PR Newswire | -0.71% | -8.36% | |
| uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – QURE | Press release | Business Wire | +0.25% | -6.67% | |
| Form 8-K uniQure N.V. For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | -1.73% | -6.85% | |
| Form 8-K uniQure N.V. For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | -1.15% | -7.22% | |
| Form 8-K uniQure N.V. For: Dec 04 | SEC filing · Form 8-K | SEC EDGAR | +7.76% | +6.96% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages uniQure N.V. (QURE) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -1.38% | +2.95% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.46% | +3.22% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against uniQure N.V. (QURE) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -1.40% | +4.62% | |
| uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.40% | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the QURE section they belong to.
Where else QURE is measured.
QURE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RTI SURGICAL (RTIX) | 925 | 0.00% | 44% |
| Zynex, Inc. (ZYXI) | 923 | -0.22% | 41% |
| ARQULE (ARQL) | 920 | 0.00% | 39% |
| HEALTH INSURANCE INNOVATIONS (HIIQ) | 919 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is uniQure N.V. - Ordinary Shares's median reaction calculated?
Every labeled QURE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 921 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 54% of QURE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does QURE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.